• Ahmed A, Bararia D, Vinayak S et al. (2004) Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine pyrimethamine resistance. Antimicrobial Agents Chemotherapy 48, 879889.
  • Ahmed A, Lumb V, Das MK et al. (2006) Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India. Antimicrobial Agents Chemotherapy 50, 39343938.
  • Andriantsoanirina V, Ratsimbasoa A, Bouchier C et al. (2010) Chloroquine Clinical Failures in P. falciparum Malaria Are Associated with Mutant Pfmdr-1, Not Pfcrt in Madagascar. PLoS ONE 5, e13281, doi:10.1371.
  • Basco KL & Ringwald P (2000) Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. American Journal of Tropical Medicine and Hygiene 62, 271276.
  • Basco LK, Eldin de PP, Wilson CM et al. (1995) Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology 69, 135138.
  • Das MK, Lumb V, Mittra P et al. (2010) High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India. Journal of Antimicrobial Chemotherapy 65, 12581261.
  • Das S, Chakraborty SP, Tripathy S et al. (2012) Association between prevalence of pyrimethamine resistance and double mutation in pfdhfr gene in West Bengal, India. Asian Pacific Journal of Tropical Disease 2012, 3135.
  • Diourte Y, Djimde A, Doumbo KO et al. (1999) Pyrimethamine-Sulfadoxine efficacy and selection for mutations in Plasmodium Falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. American Journal of Tropical Medicine and Hygiene 60, 475478.
  • Duraisingh TM, Curtis J, Warhurst CD et al. (1998) Plasmodium falciparum: Detection of Polymorphism in the Dihydrofolate Rewductase and Dihydropterate Synthase Genes by PCR and Restriction Digestion. Experimental Parasitology 89, 18.
  • Guidelines for diagnosis and treatment of malaria in India 2009. 2009, Government of India.
  • Lumb V, Das MK, Mittra P et al. (2009) Emergence of an unusual sulfadoxine pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami. Journal of Infectious Diseases 199, 10641073.
  • Sharma YD (2012) Molecular surveillance of drug-resistant malaria in India. Current Science 102, 696703.
  • Sibley CH, Hyde JE, Sims PF et al. (2001) Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 17, 582588.
  • Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369374.
  • Trager W & Jensen JB (1976) Human malaria parasites in continuous culture. Science 193, 673675.
  • Triglia T, Menting JG, Wilson C et al. (1997) Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences USA 94, 1394413949.
  • Wernsdorfer WH & Noedl H (2003) Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology. Current Opinion in Infectious Diseases 16, 553558.
  • World Health Organization (2003) Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. monitoring.pdf.